EUVIMEDEUVIMED entdecken
Kohortenstudie

Long-Term Impacts of COVID-19 on Severe Exacerbation and Mortality in Adult Asthma: A Nationwide Population-Based Cohort Study

Hyun Lee, Bo-Guen Kim, Cho Yun Jeong, Dong Won Park, Tai Sun Park, Ji-Yong Moon, Tae-Hyung Kim, Jang Won Sohn, Ho Joo Yoon, Jong Seung Kim, Sang-Heon Kim

The Journal of Allergy and Clinical Immunology: In Practice · 2024-07 · 12 (7) · 1783-1793.e4

DOI: 10.1016/j.jaip.2024.03.035 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift The Journal of Allergy and Clinical Immunology: In Practice, 2024-07. Verfasst von Hyun Lee und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: COVID-19, Asthma, SARS-CoV-2. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 48 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: In adults with asthma, the long-term impact of previous coronavirus disease 2019 (COVID-19) on severe exacerbations and mortality is unclear. OBJECTIVE: We evaluated the long-term risk of severe exacerbation and mortality in adults with asthma who recovered from COVID-19. METHODS: Using the Korean National Health Insurance claim-based database, we compared the risk of severe exacerbations (emergency room visits or hospitalization) and mortality in adults with asthma aged greater than 20 years who had recovered from COVID-19 between October 8, 2020, and December 16, 2021 (COVID-19 cohort, n = 10,739) with 1:1 propensity score-matched controls (n = 10,739). RESULTS: During a median follow-up of 87 days (range, 15-448 days), the incidence rate of severe exacerbations in the COVID-19 cohort and the matched cohort was 187.3 and 119.3 per 10,000 person-years, respectively. The COVID-19 cohort had a higher risk of severe exacerbation compared with the matched cohort (hazard ratio = 1.57; 95% CI, 1.06-2.32). During a median follow-up of 360 days (range, 15-721 days), the incidence rate of death in the COVID-19 and matched cohorts was 128.3 and 73.5 per 10,000 person-years, respectively. The COVID-19 cohort had a higher risk of death (hazard ratio = 1.76; 95% CI, 1.33-2.30) compared with the matched cohort. When further analyzed by COVID-19 severity, severe COVID-19 was associated with a 5.12-fold (95% CI, 3.27-8.01) and 7.31-fold (95% CI, 5.41-9.88) increased risk of severe exacerbation and death, respectively, but non-severe COVID-19 was not. CONCLUSIONS: Our study shows that severe COVID-19 is associated with an increased long-term risk of severe exacerbation and mortality among individuals with asthma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19AsthmaSARS-CoV-2HumansMaleFemaleAdultMiddle AgedRepublic of KoreaCohort StudiesHospitalizationAgedYoung AdultDisease ProgressionIncidenceSeverity of Illness Index

Stichwörter der Autor:innen

AsthmaCOVID-19ExacerbationMortality

Autor:innen und Institutionen

  • Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Republic of Korea.
  • Department of Medical Informatics, Jeonbuk National University Medical School, Jeonju, Republic of Korea.
  • Department of Medical Informatics, Jeonbuk National University Medical School, Jeonju, Republic of Korea; Research Institute of Clinical Medicine of Jeonbuk National University-Biomedical Research Institute of Jeonbuk N…
  • Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Republic of Korea. Electronic address: sangheonkim@hanyang.ac.kr.

Zitieren

APA

Lee, H., Kim, B. G., Jeong, C. Y., Park, D. W., Park, T. S., Moon, J. Y., Kim, T. H., Sohn, J. W., Yoon, H. J., Kim, J. S., & Kim, S. H. (2024). Long-Term Impacts of COVID-19 on Severe Exacerbation and Mortality in Adult Asthma: A Nationwide Population-Based Cohort Study. The Journal of Allergy and Clinical Immunology: In Practice, 12(7), 1783-1793.e4. https://doi.org/10.1016/j.jaip.2024.03.035

Vancouver

Lee H, Kim BG, Jeong CY, Park DW, Park TS, Moon JY, et al. Long-Term Impacts of COVID-19 on Severe Exacerbation and Mortality in Adult Asthma: A Nationwide Population-Based Cohort Study. The Journal of Allergy and Clinical Immunology: In Practice. 2024;12(7):1783-1793.e4. doi:10.1016/j.jaip.2024.03.035

BibTeX
@article{Lee2024,
  author = {Lee, Hyun and Kim, Bo-Guen and Jeong, Cho Yun and Park, Dong Won and Park, Tai Sun and Moon, Ji-Yong and Kim, Tae-Hyung and Sohn, Jang Won and Yoon, Ho Joo and Kim, Jong Seung and Kim, Sang-Heon},
  title = {Long-Term Impacts of COVID-19 on Severe Exacerbation and Mortality in Adult Asthma: A Nationwide Population-Based Cohort Study},
  journal = {The Journal of Allergy and Clinical Immunology: In Practice},
  year = {2024},
  volume = {12},
  number = {7},
  pages = {1783--1793.e4},
  doi = {10.1016/j.jaip.2024.03.035}
}
Kostenlos starten →